Novel drug candidate for the treatment of several soft ‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.

In conclusion, a computational method was used to identify Bepridil as a potential candidate for the treatment of several common STS histologic subtypes. Experimental validation of these in silico results is necessary before clinical translation can occur. PMID: 30816547 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30816547?dopt=Abstract

Source: Oncology Reports - March 4, 2019 Category: Cancer & Oncology Tags: Oncol Rep Source Type: research